Login / Signup

Direct oral anticoagulants versus warfarin in patients with single antibody-positive anti-phospholipid syndrome.

Angela LiuKarishma Vijay RupaniLeonard Naymagon
Published in: European journal of haematology (2022)
These findings suggest that DOACs may be a safe and effective option for patients with single-positive APLS. Prospective studies are needed to confirm these findings.
Keyphrases
  • direct oral anticoagulants
  • venous thromboembolism
  • atrial fibrillation
  • fatty acid
  • oral anticoagulants